ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study

Disclosure

Y.K.’s relevant financial activities outside the submitted work include CHUGAI PHARMACEUTICAL CO., LTD.; TAIHO PHARMACEUTICAL CO., LTD.; Yakult Honsha Co. Ltd; ASAHI KASEI PHARMA CORPORATION Otsuka Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; ONO PHARMACEUTICAL CO., LTD.; TSUMURA & CO. Kyouwa Hakkou Kirin Co., Ltd.; EA Pharma Co., Ltd.; MEDICON INC. KAKEN PHARMACEUTICAL CO. LTD.; Eisai Co., Ltd.; Otsuka Pharmaceutical Factory Inc.; TEIJIN PHARMA LIMITED; NIHON PHARMACEUTICAL CO., LTD.; Nippon Covidien Inc.; SHIONOGI & CO., LTD.; Ethicon, Inc.; Olympus Corporation Bristol-Myers Squibb K.K.; AstraZeneca K.K.; MSD K.K.; Smith & Nephew K.K.; ASKA Pharmaceutical Co., Ltd.; and MIYARISAN PHARMACEUTICAL CO., LTD.

留言 (0)

沒有登入
gif